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Abbreviations. Acetylated bovine serum albumin (BSA), N,N-Dimethylformamide (DMF), 
Dimethylsulfoxide (DMSO), N,N-Diisopropylethylamine (DIEA), rac-Dithioerythrol (DTT), 4-
Hydroxy-β-cyano-cinnamic acid (4-HCCA), (N-[2-Hydroxyethyl]piperazine-N-[2-ethane-
sulfonic acid] (HEPES), 1-Hydroxybenzotriazole (HOBt), 1-Hydroxybenzotriazolyl-tetramethyl-
uronium hexafluorophosphate (HBTU), Trifluoroacetic acid (TFA), Trishydroxymethyl-
aminomethane (TRIS). 
Materials. Boc-β-Ala-PAM resin (0.59 mmol/g), anhydrous HOBt and HBTU were purchased 
from Peptides International. SASRIN resin and all Fmoc/tBu protected α-amino acids were 
from Bachem, TFA was from Halocarbon, and DMSO was from Fisher scientific. All other 
solvents and reagents were anhydrous and/or ACS grade purchased from VWR or Aldrich and 
used as received. Water was purified using a Millipore MilliQ water purification system 
(18 MΩ). Biochemical experiments were performed using RNase free water (Invitrogen). DNase 
I and calf thymus DNA were purchased from Amersham, all other enzymes and materials for 
molecular biology was from Roche. All buffers were 0.2 µm filtered before storage. 
Oligonucleotide oligomers were from Integrated DNA Technologies Inc. 
Methods. UV spectra were recorded on a HP8452A diode array spectrophotometer. All 
polyamide compound concentrations were determined by UV spectroscopy (H2O) employing 
ε = 69500 Lmol-1cm-1 at λmax near 312 nm. ESI and MALDI-TOF mass spectra were recorded at the 
CalTech mass spectrometry service facility on a Finnigan LC-Q (2 µM in 50% acetonitrile, 
5 µL/min) or a Perseptive Biosystems Voyager instrument (5 pmol samples in 4-HCCA matrix). 
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Analytical HPLC was performed on a Beckman Gold HPLC System fitted with a diode array 
detector and a Varian-RP18 microsorb column (250 × 4.6 mm) at 1 mL/min, 0-100% CH3CN in 
0.1% TFA (v/v) in 30 min. Preparative HPLC was performed on a Beckman Gold HPLC System 
fitted with a diode array detector and a Waters DeltaPak-RP18 column (25 × 100 mm) equipped 
with a guard, at 8 mL/min (0-50% CH3CN in 0.1% TFA in 50 min, Method #1), or a DeltaPak-
RP18 column (25 × 100 mm) equipped with a guard attached to a Varian Dynamax-RP18 
column (21.4 × 250 mm), at 16 mL/min (0-40% CH3CN in 0.1% TFA in 70 min, Method #2). 
Polyamide. Polyamide 1 was synthesized by manual solid phase synthesis following established 
procedures.[1] Cleavage from PAM resin was accomplished by aminolysis with neat Dimethyl-
aminopropylamine (37°C, 12 h). The volatiles were removed in vacuo, the residue taken up in 
10% AcOH and purified by prep. HPLC (Method #2). HPLC 14.6 min. MS (ESI) [M+H]+ calcd 
for C59H76H23O10 1266.6, found 1266.4. 
Protected peptide acid synthesis. tBu-protected peptide acids were synthesized by manual solid 
phase synthesis on SASRIN resin.[2] In brief, 125 mg of SASRIN resin (1.08 mmol eq/g) 
were placed in a presiliconized peptide synthesis vessel, preswollen in CH2Cl2 (10 min), and 
combined with a premixed (30 min) and filtered solution of Fmoc-Gly-OH (150 mg, 0.5 mmol, 
4 eq) in DMF (125 µL) and DCC (500 µL, 1.0 M in CH2Cl2, 0.5 mmol, 4 eq). DMAP (6 mg, 
0.05 mmol, 0.1 eq) was added, and the mixture was shaken for 12 h. After draining and washing 
(CH2Cl2, DMF, CH2Cl2), the loaded resin was capped by treatment with benzoyl 
chloride/pyridine/CH2Cl2 1:1:3 (1.25 mL) for 30 min. Fmoc deprotection was in general 
achieved by treatment with 25% piperidine in DMF (3 ×; 2 sec, 30 sec, 15 min), but the second 
residue was deprotected with 50% piperidine in DMF (3 ×; 2 sec, 30 sec, 5 min). Amino acid 
coupling was performed for 1.5 h at r.t. using a solution of 0.3 mmol Fmoc/tBu protected amino 
acid in DMF (0.7 mL) preactivated with 0.3 mmol HOBt, 0.27 mmol HBTU and 50 µL of DIEA 
for 5 min. After 15 min of coupling time, more DIEA (20 µL) was added to the mixture. After 
successive build-up of the peptide chain, the terminal Fmoc group was removed and the resin 
bound peptide treated with a mixture of Ac2O/pyridine/DMF 2:3:10 (1 mL) for 30 min followed 
by thorough washing (DMF, iPrOH, DMF, CH2Cl2). The peptide was cleaved from the resin in 
four cycles, where the resin was treated with TFA/Ethanedithiol/Et3SiH/CH2Cl2 1:5:5:89 
(1.5 mL) for 15 min. After each cycle, the resin was drained, and the obtained solution was 
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immediately cooled to 0°C and neutralized with pyridine (20 µL). All cleavage solutions were 
combined and partitioned between EtOAc (70 mL) and 0.1 M KHSO4 (30 mL). The organic layer 
was washed with brine (2 × 20 mL), dried with Na2SO4, and the volatiles were evaporated. Puri-
fication of the residue by flash column chromatography (20 g of silica) yielded the pure peptide 
acids. Peptide 4: Yield 148.5 mg (121 µmol, 88%); TLC (CH2Cl2/MeOH/HCOOH 100:5:1) 
Rf = 0.16; HPLC 23.4 min; MS (ESI, neg.) [M-H]- calcd for C63H86N9O14S 1224.6, found 1224.5. 
Peptide 5: Yield 54.2 mg (57 µmol, 42%); TLC (CH2Cl2/MeOH/HCOOH 100:10:1) Rf = 0.19; 
HPLC 18.0 min; MS (ESI, neg.) [M-H]- calcd for C48H69N8O12 949.5, found 949.5. 
 
Synthesis of the polyamide-peptide conjugates. A solution of 10 µmol (4 eq.) of the respective 
peptide acid in CH2Cl2/DMF 10:1 (2.5 mL) was treated at r.t. with 0.1 M HBTU in DMF 
(110 µL, 11 µmol) and 1.0 M DIEA in DMF (12 µL, 12 µmol) for 5 min, before approx. 
2.5 µmol of polyamide 1 TFA salt in DMF (2.5 mL) were added, followed by 12 µL of 1.0 M 
DIEA in DMF. After the conversion was complete (2h, HPLC control), the volatiles were 
removed in vacuo, and the residue was dissolved in TFA/CH2Cl2/Ethanedithiol/Et3SiH 80:10:5:5 
(1 mL). After 20 min, the crude peptides were precipitated with cold Et2O (10 mL, 0°C) and 
isolated by centrifugation and discarding of the supernatant. The colorless powder was resuspen-
ded twice in Et2O (5 mL, 0°C), reisolated by centrifugation, and then taken up in 0.2 M AcOH. 
After standing for 4 h, this solution was purified by prep. HPLC (Method #1) to yield the 
conjugates in >97.5% HPLC purity (312 nm). Conjugate 2: Yield 3.7 mg (1.66 µmol, 62%) from 
4 and 2.67 µmol 1; HPLC 17.0 min; MS (MALDI-TOF) [M+H]+ calcd for C108H137N32O19S 
2218.1, found 2218.0. Conjugate 3: Yield 1.4 mg (0.72 µmol, 26%) from 5 and 2.8 µmol 1; 
HPLC 15.5 min; MS (MALDI-TOF) [M+H]+ calcd for C98H128N31O19 2043.0, found 2042.9. 
DNase I footprinting. Dissociation constants for the DNA binding of compounds 1, 2 and 3 
were obtained following published protocols.[3] All reactions were carried out in 400 µL total 
volume employing 20 kcpm of a 3-radiolabelled 250-bp restriction fragment from the plasmid 
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pDEH9 (Figure S1 a). No carrier DNA was used in the equilibration, and the solutions were 
allowed to equilibrate for 12 h at 22°C in TKMC buffer (10 mM TRIS, 10 mM KCl, 5 mM 
MgCl2, 5 mM CaCl2; pH 7.0) prior to the DNase I digestion. Reaction products (8 kcpm) were 
resolved on denaturing 8% polyacrylamide sequencing gels run at 55 W. 
 
Figure S1. a) Overall composition and insert sequence of the EcoRI/PvuII restriction fragment from the plasmid pDEH9. Polyamide 
binding sites are highlighted with boxes, mismatched base pairs are shaded in gray. The site of the 3-32P-labeling is indicated 
(lower strand). b)-d) Quantitative DNAse 1 footprint titration experiments for compounds 1, 2 and 3 on the 3-32P-labeled 250-bp 
EcoRI/PvuII restriction fragment from the plasmid pDEH9. Lane 1: Intact DNA. Lane 2: A-reaction. Lane 3: G-reaction. Lane 4: 
DNAse 1 standard. b) Compound 1 Lane 5-17: 50 nM, 20 nM, 10 nM, 5 nM, 2 nM, 1 nM, 500 pM, 200 pM, 100 pM, 50 pM, 20 pM, 
10 pM, 5 pM; c) Compound 2 Lane 5-17: 500 nM, 200 nM, 100 nM, 50 nM, 20 nM, 10 nM, 5 nM, 2 nM, 1 nM, 500 pM, 200 pM, 100 
pM, 50 pM; d) Compound 3 Lane 5-17: 1 µM, 500 nM, 200 nM, 100 nM, 50 nM, 20 nM, 10 nM, 5 nM, 2 nM, 1 nM, 500 pM, 200 pM, 
100 pM, respectively. The analyzed binding site locations are indicated with square brackets along the left side of each autoradio-
gram. 
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Protein expression. Drosophila extradenticle (Exd) protein comprising the homeodomain and 
the extended fourth helix (residues 238-324),4 as well as ultrabithorax (Ubx) protein homeo-
domain (residues 233-313 of the Ubx isoform IVa) was expressed and purified after Passner and 
Aggarwal.5 The purified proteins Exd and Ubx were used for EMSA studies as described below. 
 
EMSA (gel shift) studies.  
For the templates, following DNA oligos were used (see below). The DNA upper strand was 
annealed with the respective matching lower strand and both strands were 5-labeled with γ-32P-
ATP and polynucleotide kinase, using standard procedures. 
 
Figure S2. DNA duplexes used for the EMSA studies. The binding site for the Exd protein is marked by a box, the polyamide or Hox 
protein binding site is shown in boldface. a) Optimal template; b) 2-bp mismatch in the Exd site; c) 2-bp mismatch in the PA binding 
site; d) composite Ubx-Exd binding site (see ref. 5). 
 
Gel-shift experiments: The master mix contained 50% BSA/50% glycerol, reaction buffer (150 
mM potassium glutamate, 50 mM HEPES pH 7.0, 1 mM DTT) and 5end labeled DNA (32P). 
The final concentrations in the samples were 100 ng/µL BSA and 10% glycerol. Polyamides 
were kept in subdued lighting whenever possible. Upon addition of the polyamide to 1 pM DNA 
the samples were incubated at 25°C for 30 minutes in a 20 µL reaction.  Next, Exd was added to 
the samples and incubated for 1 hour at 4°C. A 9% acrylamide/3% glycerol gel was pre-run for 
15 min prior to loading. In each lane 15 µL of a 20 µL reaction were loaded while the gel was 
running, to prevent the samples from being diluted. The gels were run at 4°C / 185 V. Gels were 
dried, exposed to a phosphorimager screen, and visualized using a Molecular Dynamics 
phosphorimager.  
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Figure S3. EMSA studies with polyamides 1-3, Exd and Ubx. a) Each polyamide binds and decreases the mobility of free DNA 
(lanes 2-18). Compound 2 bearing the functional docking peptide is capable of recruiting Exd to DNA (lanes 9-12) whereas 1 & 3 
are not. In lanes 2-6, 8-12, 14-18, Exd was added in following concentrations: 0, 3, 10, 30, 100 nM.  Lanes 19 and 20 contained 
DNA bearing the Exd-Ubx binding site that was used in X-ray crystal structure determination (see methods above for sequence).  In 
the reaction shown in lane 20, 275 nM Ubx and 30 nM Exd were incubated with DNA. b) Multiple Exd molecules bind DNA at 1 µM 
concentration (lane 2), reactions in lanes 3-7 contain 50 nM PA 2 and increasing concentration of Exd (0, 0.3, 1, 3, 10 nM in lanes 3-
7). 
 
Gel-shift studies with the Ubx protein were performed under identical buffer conditions using the 
duplex oligonucleotide listed in Figure S2 (d). Ubx was added to the reaction mixture containing 
32P end-labeled duplex DNA and incubated at 4°C for 30 min. Subsequently Exd was added and 
the reaction was further incubated for 60 min at 4°C. The complexes were resolved under similar 
gel conditions as those described for DNA-polyamide-Exd complexes above. The Kd of Ubx for 
its cognate DNA was found to be 200 ± 25 nM. Under saturating concentrations of Ubx (325 nM) 
the affinity of Exd for the binary [Ubx-DNA] complex was 2-3 fold larger than the affinity of 
Exd for the conjugate 2·DNA binary complex.6 
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